Gleeson, M., Peckitt, C., To, Y., Edwards, L., Chau, I., Johnson, P., Ardeshna, K., Wotherspoon, A., Attygalle, A., Begum, R., Chua, S., Zerizer, I., Hawkes, E., Macheta, M., Collins, G., Radford, J., Forbes, A., Hart, A., Montoto, S., McKay, P., Benstead, K., Morley, N., Kalakonda, N., Hasan, Y., Turner, D., & Cunningham, D. (n.d.). cHOP VERSUS GEM‐P IN THE FIRST‐LINE TREATMENT OF T‐CELL LYMPHOMA (PTCL): INITIAL RESULTS OF THE UK NRCI PHASE II RANDOMISED CHEMO‐T TRIAL. Hematological oncology, 35, 75–76. http://access.bl.uk/ark:/81055/vdc_100047420108.0x000035